Search the Community
Showing results for tags 'biomarker testing'.
I've seen a lot of change in my life. TV -- 3 broadcast channels to hundreds of cable and satellite channels to streaming watch on demand. Music -- from a 9 volt AM transistor radio to thousands of songs on my smart phone. Telephone -- from 5 families sharing a "party line" to a video chat with my granddaughter. I could go on and on. But most significant to me are the advances in treating lung cancer discovered and fielded in the last 14 years. My diagnosis was a near death sentence. Today, there are so many more options with effective treatments for the newly diagnosed. This Forbes article does a wonderful job of explaining the remarkable advances in treatments that are available for those newly diagnosed with lung cancer. Once our most effective and reliable treatment, hope, is slowing giving way to methods that provide significant life after diagnosis. Spread the word... and.... Stay the course. Tom
Having enough tissue available for biomarker (aka mutation, genetic, or molecular) testing can also be an important consideration. Before a biopsy is done, the patient should speak with his or her oncologist about having the tumor sample profiled. To find out if targeted cancer therapy makes sense for an individual with lung cancer, that person’s tumor tissue will be tested. The goal is to determine whether or not an appropriate target is present. The following video describes diagnostic testing for mutations in lung cancer.